The granting of emergency use authorization by the U.S. FDA to Roche AG for its four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and respiratory syncytial virus will allow the company ...
The BA.2.75 sublineage of the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may escape neutralizing antibodies. The BA.2.75 sublineage (primarily the BA.2 ...
The arrival of SARS-CoV-2, the virus responsible for COVID-19, brought a batch of vocabulary into the public eye, from "fomite" to "social distancing." See our guide from 2020. And now there's a new ...
Research reveals a sharp decline in both the effectiveness and duration of protection from prior infection post-Omicron, underscoring the need for updated vaccines to sustain immunity Study: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback